Dec. 4 (UPI) -- Israel and biotech firm Moderna signed an agreement Friday for millions more doses of the company's COVID-19 vaccine, which has shown to be 94% effective.
The deal increases the number of doses earmarked for Israel from 2 million to 6 million.